EA
GSK icon

Eudaimonia Advisors’s GSK GSK Stock Holding History

Eudaimonia Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$707K Buy
+16,499
New +$680K 0.38% 79
2022
Q2 		– Sell
-4,814
Closed -$262K – 159
2022
Q1 		$262K Sell
4,814
-197
-4% -$10.7K 0.15% 138
2021
Q4 		$276K Buy
+5,011
New +$261K 0.16% 133

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eudaimonia Advisors's GSK Position: Q1 2024 in Review

Eudaimonia Advisors opened a new position in GSK (GSK) in Q1 2024: 16,499 shares worth $707K. The stake represents 0.38% of the portfolio and ranks #79 among its holdings. This is a return to the name: Eudaimonia Advisors previously reported a position in GSK as recently as Q1 2022.

Eudaimonia Advisors first reported a position in GSK in Q4 2021 and has held it in 3 quarters since. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Eudaimonia Advisors held 16,499 shares of GSK worth $707K as of Q1 2024.
  • GSK was a new Eudaimonia Advisors position in Q1 2024.
  • GSK made up 0.38% of Eudaimonia Advisors's portfolio in Q1 2024, its #79 holding.
  • Eudaimonia Advisors first reported a position in GSK in Q4 2021 and has held it in 3 quarters since.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Eudaimonia Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.